Anti-MMP9
Abcam ab38898 WB 1000 eventually confirmed by histopathology, according to the American Association for the Study of Liver Diseases guidelines. [1] All patients were older than 18 years of age with complete clinical and laboratory data. The inclusion criteria were that the samples contained matched tumors (percentage of tumor cells >70%) and corresponding normal liver tissue (>5 cm laterally from the edge of the cancerous region), the patient had a single primary lesion, and no adjuvant therapy. The patients who had the history of other solid tumors, had the secondary liver cancer from other primary regions, with mixed hepatocellular carcinoma and cholangiocarcinoma were excluded from this study. Patients were regularly followed up at the outpatient clinics 
Real-time quantitative RT-PCR (qPCR)
Total RNA was extracted and purified using TRIzol reagents (Invitrogen, Carlsbad, CA) and RNeasy mini kit (Qiagen Inc, Valencia, CA) according to the manufacturer's instructions. The relative mRNA levels were determined by reverse transcription and qPCR with Sybr Green dye (Invitrogen) as described previously. [2] For miRNA analysis, cDNAs were synthesized using the PrimeScript RT reagent kit (Takara). Then, qPCRs were performed by using the Takara SYBR Premix Ex Taq II (Takara) and the 7500 Real-Time PCR System (Applied Biosystems). Quantitative real-time PCR (qRT-PCR) analysis of miR-125b-5p was performed by using a commercially purchased kit specifically designed for quantifying this miRNA (TaqMan MicroRNA Assay Kit, Applied Biosystems, Foster City, CA). The expression of miRNA was defined based on the threshold cycle (Ct), and relative expression levels were calculated as 2 -[(Ct of miR-125b-5p) -(Ct of U6)] after normalization with reference to expression of U6 small nuclear RNA. 
Western blotting analysis

Plasmids and stable cell lines
The pre-miR-125b-1 was synthesized by Invitrogen and ligated into the EcoR I/ Bgl II sites of the pMSCV-neo vector. For establishment of miR-125b-5p overexpression stable cell lines, pMSCV-neo-miR-125b-1 plus with pVPack-GP and pVpack-VSV-G were co-transfected into 293T cells to package viral particles. The viruses were collected and infected HCCLM3 and HUH7 cells. 48 h after infection, the cells were selected with G418-containing (500 g/ml) medium for at least 10 days.
Then the expression of miR-125b-5p was detected by quantitative real-time PCR. The expression of miR-125b-5p was defined based on the threshold cycle (Ct), and relative expression levels were calculated as 2 -[(Ct of miR-125b-5p) -(Ct of U6)] after normalization with reference to expression of U6 small nuclear RNA. After validating the successful overexpressing miR-125b-5p, the cells were maintained in a low concentration of G418 (200 g/ml) containing medium and the expression of miR-125b-5p was assessed monthly.
Wound-healing assays
For wound-healing assays, transfected cells were plated in six-well plates, and cells were maintained in serum-free medium. When the HCCLM3 and HUH7
including miR-125b-5p group, negative control group and blank control group confluence reached 80-90%, a scratch was made using a 10-l pipette tip, after serum starved for 24 h. The wounded monolayer was washed with PBS and imaged 48 h after scratching using an Olympus camera system. Wound healing assays were conducted in triplicate.
Cell invasion assay
For invasion assays, three groups of HCCLM3 and HUH7 were resuspended in 200 l of serum-free DMEM medium and seeded onto Boyden chambers (Corning, NY, USA) coated with Matrigel. The chambers were then incubated in DMEM with 20% FBS at 37 °C in 5% CO 2 . After 24 h, the cells adhering to the chamber's lower surface were fixed, whereas cells remaining on the upper surface were removed. After staining in a dye solution containing 0.05% crystal violet, the cells from three randomly selected high power fields were counted under a microscope (Olympus, Tokyo, Japan). Invasion assays were conducted in triplicate.
Tube formation assay
The HUVEC cells commercially obtained from Vec Technologies (Rensselaer, NY), and the tube formation assay was carried out as described. [3] In brief, 96-well plates were coated with 50 l Matrigel. 2 × 10 4 HUVEC cells were added to each well and incubated respectively in medium preconditioned with three groups of HCCLM3
and HUH7 cells at 37°C for 6-8 h. Images were acquired under an inverted microscope. Angiogenesis potential was quantified by measuring the length of tube walls formed between discrete endothelial cells in each well relative to the control.
Tube formation assays were conducted in triplicate.
Flow cytometry
Three groups of HCCLM3 and HUH7 were digested using trypsin and resuspended at 1×10 6 cells per mL in DMEM that contained 2% FBS and pre-incubated at 37°C for 30 min with or without 100 M verapamil (Sigma-Aldrich, 1711202) to inhibit ABC transporters. Cells were subsequently incubated for 90 min at 37°C with 5 g/ml Hoechst 33342 (Sigma-Aldrich B2261). Then, cells were incubated on ice for 10 min and washed with ice-cold PBS before flow cytometry analysis. Data were analyzed using Summit 5.2 software (Beckman Coulter).
Sphere formation assay
Various cells (1000 cells per well) were plated onto a 24-well ultra-low attachment plate (Corning) in serum free DMEM/F12 medium supplemented with N2 plus media supplement (Invitrogen), 20 ng/ml epidermal growth factor (Invitrogen), 20 ng/ml basic fibroblast growth factor (Invitrogen) and 4 mg/ml heparin (Sigma-Aldrich). After 10 days of culture, the number of spheres larger than 50 m was counted under an inverted microscope. The spheres were photographed under a microscope and the diameters of spheres were measured. After counting sphere numbers, all tumor spheres were collected by spin down and trypsinized into single cells. The total cell number divided by the sphere number is the average cell number of each sphere. Sphere formation assays were conducted in triplicate.
Vectors construction
The 3 Twenty four hours later, the miR-125b-5p mimics were transfected into the cells.
Another 48 h later, cells were collected and suspended in lysis buffer (Promega, Madison, WI, USA), and luciferase activities were monitored for luciferase and renilla activity using reagents in dual-luciferase reporter assay kit and a luminometer 
Synthesis and characterization of delivery agents
The Folate-conjugated block copolymer, Fa-PEG-g-PEI, was synthesized according to the previously described method. [4] Briefly, HO-PEG-NH 2 [5] and folic acid (1 g) were dissolved in anhydrous DMSO (20 mL). N-hydroxysuccinimide (NHS, 0.9 g) and dicyclohexylcarbodiimide (DCC, 0.5 g) were added and the mixture was stirred overnight at room temperature. Under an argon atmosphere, the mixture was filtrated through the 0.22 m syringe filter to remove 1,3-dicyclohexyl urea (DCU), and then the filtrate was mixed with a DMSO solution of HO-PEG-NH 2 (0.53g) and TEA (pH 8.0). The mixture was allowed to react for 24 h at room temperature, dialyzed against deionized water (MWCO: 1000 Da), and lyophilized. Fa-PEG-OH thus prepared was converted into Fa-PEG-COOH by reaction with succinic anhydride (SA). Fa-PEG-OH and SA in a 1:5 molar ratio were dissolved in 20 mL anhydrous chloroform and refluxed at 70°C for 48 h. After chloroform was removed by distillation, polymer was re-dissolved in 20 mL deionized water and dialyzed against water for two days to remove succinic acid and succinic anhydride. Polymer solution was freeze-dried to obtain Fa-PEG-COOH. Finally, hyperbranched PEI 25 kDa, Fa-PEG-COOH and NHS were dissolved in DMSO and magnetically stirred for 24 h at room temperature to produce Fa-PEG-g-PEI. The solution was dialyzed (MWCO:
14000 Da) in distilled water for 3 day and then lyophilized. Nontargeted mPEG-g-PEI was synthesized using the same approach.
Preparation of magnetic nanocarriers (Fa-PEG-g-PEI-SPION)
SPION was complexed with Fa-PEG-g-PEI by the ligand exchange method as reported. [6] In brief, Fa-PEG-g-PEI (200 mg) was dissolved in 2 mL of chloroform, and SPION (10 mg) was dispersed into the solution. The reaction mixture was stirred overnight at room temperature before precipitating into large amount of hexane. The precipitate was collected by centrifugation, washed twice with hexane and vacuum-dried. The product thus prepared was dispersed into double distilled water under sonication and filtered through a 220 nm membrane to remove large aggregates.
Nanomedicine formation.
miR-125b-5p or negative control-miR plasmid (4 mg) and an appropriate amount of nanocarrier were dissolved separately in 0.9% sodium chloride solution. The two solutions were mixed by vigorous pipetting and then kept at room temperature for 60 min to allow polyplex formation. The amount of delivery agent (Fa-PEG-g-PEI-SPION) to complex plasmid was based on the designed experimental N/P ratio (10), which was calculated as the number of nitrogen atoms in delivery agents over that of the phosphate groups in plasmids.
In vitro and vivo MRI
The HCCLM3 or HUH7 cells cultured in vitro were imaged using a clinical 1.5-T MRI system (Achieva; Philips Medical Systems, Best, the Netherlands) with an 11-cm circular coil. Fast spin echo (FSE) T2-weighted images were acquired using the following parameters: TR/TE = 500/15 ms, number of signal acquisitions (NSA) = 2; TR/TE = 2600/100 ms, NSA = 4; FOV = 70-80 mm, matrix = 256 × 256, section thickness = 1.5 mm.
In vivo MRI was performed after tail vein injection of nanomedicines for 2 hours in each group to detect the size and signal of the tumour using a clinical 1.5-T system (Achieva; Philips Medical Systems) with a 50× 69 mm linearly polarised birdcage radio frequency rat coil (Shanghai Chenguang Medical Technologies, China). Axial liver images were obtained using T2-weighted imaging (TR/TE = 2600/100 ms; NSA = 3); FOV = 70 mm, matrix = 256 × 256, and section thickness = 1.0 mm.
Fluorescence study on in vitro cellular
To enable confocal laser scanning microscopic (CLSM) observation of the cells after incubation, the nanocarrier Fa-PEG-g-PEI-SPION and pDNA were labeled with
Oregon Green 488 and POPO-3, respectively, according to the manufacturer's protocols. [7] HCCLM3 or HUH7 cells were seeded at a density of 5×10 5 cells per well in 6-well plates. The POPO-3 labeled pDNA was complexed with the Oregon Green-labeled nanocarrier at N/P=10. The formed polyplex (at Fe concentrations of 20 g/mL) was then added into culture medium. After 0.5 h, cells were washed 3 times with fresh PBS free of polyplex, fixed and further incubated by the nucleus DNA-staining agent DAPI. CLSM observation was carried out using a Zeiss LSM 510 META microscope (Carl Zeiss Co., Ltd., Gottingen, Germany).
Animal experiment
Male BALB/c nude mice (4-5 weeks old, 18-20 g) were purchased from Vital River Laboratories (Beijing, China) and were housed in a barrier facility on a 12 h light/dark cycle in the Center for Experimental Animals of Sun Yat-Sen University.
All studies involving animals were approved by the Institutional Animal Care and Use calibration. [8, 9] Prussian blue staining Prussian blue staining was performed on the tumor tissues from each animal to identify the presence of ferric iron (Fe). The slides were thawed and hydrated in distilled water for 2 minutes, followed by transfer to 1:1 solution of 10% potassium ferrocyanide (Sigma-Aldrich) and 20% HCl for 20 minutes. After rinsing with distilled water, the slides were counterstained by nuclear-fast red (Sigma-Aldrich) solution for 5 minutes. Slides were then washed in distilled water for 5 minutes and dehydrated in increasing concentrations of ethanol (70%, 80%, 90%, 95%, and 100%)
followed by xylene (2× 3 minutes), and afterwards coverslipped with PermountTM (Sigma-Aldrich). Tumor tissues after Prussian blue staining were observed using an Olympus BX40 microscope with a SPOT RT3 digital camera (Diagnostic Instruments
Inc., Stirling Heights, MI, USA) under bright field illumination.
Immunofluorescence assay and Immunohistochemistry assay
Tumor samples from HCCLM3 or HUH7 cells were fixed 10% buffered formalin and embedded in paraffin. 4 m thick tissue sections were cut. All sections were deparaffinnized and dehydrated with graded alcohol. The sections were then washed 10 min in phosphate-buffered saline (PBS) (pH 7.2). The endogenous peroxidase activity was quenched by incubation in methanol containing 3% H 2 O 2 for 10 min at room temperature, then heated for 30 min at 95°C to repair antigens and finally rinsed in PBS. After several washes in PBS, the sections were blocked with goat serum for 20 min at room temperature, and then incubated with CD133 or CD34 primary antibodies overnight at 4°C in a humidified chamber. Replacing the primary antibodies by PBS, negative control staining was using performed, the slides were treated with polymer enhancer (Reagent A) for 20 min at room temperature. After a complete wash in PBS, the slides were treated with fluorescent secondary antibodies for 30 min at room temperature. After a complete wash in PBS, the slides were develop in freshly prepared diaminobenzedine solution (DAB) for 8 min, and then counterstained with hematoxylin, dehydrated, airdried, and mounted.
In addition, some slides of HCCLM3 or HUH7 tumors were pretreated with an antigen retrieval method by heating the slides in an autoclave in citrate buffer (10 mM, 
Statistical analysis
The data are expressed as the means ± standard deviation (S.D.). Experimental data were analyzed by Student's t-tests for two groups and two-way analysis of variance for multiple groups. All statistical tests were performed using SPSS 16.0 software (SPSS, Inc., Chicago, IL), and statistical significance was set at P < 0.01.
